Titan Medical (TMDIF) Competitors

Titan Medical (NASDAQ:TMDIF) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability.

Does the media prefer TMDIF or LNSR?

In the previous week, LENSAR had 1 more articles in the media than Titan Medical. MarketBeat recorded 4 mentions for LENSAR and 3 mentions for Titan Medical. LENSAR's average media sentiment score of 1.18 beat Titan Medical's score of 0.42 indicating that LENSAR is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Titan Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LENSAR	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is TMDIF or LNSR more profitable?

Titan Medical has a net margin of 0.00% compared to LENSAR's net margin of -34.03%. LENSAR's return on equity of -49.02% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
LENSAR	-34.03%	-49.02%	-21.12%

Do analysts prefer TMDIF or LNSR?

LENSAR has a consensus price target of $15.00, indicating a potential upside of 6.76%. Given LENSAR's stronger consensus rating and higher probable upside, analysts plainly believe LENSAR is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
LENSAR	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more risk & volatility, TMDIF or LNSR?

Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500.

Do insiders & institutionals believe in TMDIF or LNSR?

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 40.2% of LENSAR shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 66.0% of LENSAR shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has higher valuation & earnings, TMDIF or LNSR?

Titan Medical has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.86	$6.95M	$0.05	5.75
LENSAR	$53.49M	3.10	-$14.38M	-$2.72	-5.17

Does the MarketBeat Community prefer TMDIF or LNSR?

LENSAR received 6 more outperform votes than Titan Medical when rated by MarketBeat users.

Company	Underperform	Outperform
Titan Medical	N/A	N/A
LENSAR	Outperform Votes 6 37.50%	Underperform Votes 10 62.50%

Summary

LENSAR beats Titan Medical on 11 of the 16 factors compared between the two stocks.